Patient Organizations Are Starting to Risk Their Financial Ties to Big Pharma by Opposing High Drug Prices
According to a story from Xconomy National, some patient advocacy organizations are beginning to speak out about exorbitantly high drug prices despite the fact that many of them receive funding…